Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The American Society of Clinical Oncology (ASCO) 2020 annual congress scheduled for May 29-June 2 in Chicago, will be replaced by a virtual edition.

ASCO 2020

29 May–02 June 2020 | Virtual Meeting

ASCO 2020

29 May–02 June 2020 | Virtual Meeting

The American Society of Clinical Oncology (ASCO) 2020 annual congress scheduled for May 29-June 2 in Chicago, will be replaced by a virtual edition.

EHA and ASCO 2020 – what data will impact clinical practice? 4:32
EHA and ASCO 2020 – what data will impact clinical practice?
Joshua Richter • 7 Jul 2020
Defining newly diagnosed high-risk MM 3:08
Defining newly diagnosed high-risk MM
Joshua Richter • 7 Jul 2020
David C. Fajgenbaum: Chasing My Cure 8:40
David C. Fajgenbaum: Chasing My Cure
David C. Fajgenbaum • 1 Jun 2020
Safety and efficacy of allogenic CAR-T cell treatment 2:53
Safety and efficacy of allogenic CAR-T cell treatment
Sattva Neelapu • 29 May 2020
ZUMA-1: safety and efficacy of axicabtagene in refractory non-Hodgkin lymphoma patients 2:48
ZUMA-1: safety and efficacy of axicabtagene in refractory non-Hodgkin lymphoma patients
Sattva Neelapu • 29 May 2020
Combining hypomethylating agents in AML 5:08
Combining hypomethylating agents in AML
Amer Zeidan • 1 Jun 2020
Significance of oral hypomethylating agents 3:51
Significance of oral hypomethylating agents
Amer Zeidan • 1 Jun 2020
Hypomethylating agents in AML 3:08
Hypomethylating agents in AML
Amer Zeidan • 1 Jun 2020
Highlights in multiple myeloma at ASCO 2020 9:58
Highlights in multiple myeloma at ASCO 2020
Thomas Martin • 1 Jun 2020
Updates from the MEDALIST study 3:58
Updates from the MEDALIST study
Amer Zeidan • 1 Jun 2020
Glasdegib in combination with azacitidine in MDS, AML and CMML 3:32
Glasdegib in combination with azacitidine in MDS, AML and CMML
Amer Zeidan • 1 Jun 2020
ASCO 2020: BiTEs in multiple myeloma 9:42
ASCO 2020: BiTEs in multiple myeloma
Thomas Martin • 1 Jun 2020
KarMMa: Idecabtagene vicleucel for R/R MM 5:34
KarMMa: Idecabtagene vicleucel for R/R MM
Nikhil Munshi • 1 Jun 2020
Venetoclax plus dose-adjusted R-EPOCH for Richter’s syndrome 3:08
Venetoclax plus dose-adjusted R-EPOCH for Richter’s syndrome
Matthew Davids • 1 Jun 2020
ALPHA Trial: ALLO-501 in Relapsed/Refractory Non-Hodgkin Lymphoma 3:07
ALPHA Trial: ALLO-501 in Relapsed/Refractory Non-Hodgkin Lymphoma
Sattva Neelapu • 29 May 2020
COVID-19 in Wisconsin, USA 3:21
COVID-19 in Wisconsin, USA
Nirav Niranjan Shah • 18 May 2020
The content of VJHemOnc is intended for healthcare professionals